COSCIENS Biopharma Inc. Stock
Stocks
CSCI
CA22112H2000
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.700 CAD | -0.65% |
|
+1.99% | -9.62% |
| 07-03 | COSCIENS Biopharma Completes Share Capital Amendment | MT |
| 06-18 | Cosciens Biopharma Inc. Announces Appointment of Peter H. Puccetti as Permanent CEO, Effective June 18, 2026 | CI |
| Market Cap | 5.84M 5.13M 4.77M 4.39M 8.23M 565M 8.37M 57.03M 22.24M 276M 21.91M 21.44M 957M | P/E 2024 |
-0.45x | P/E 2025 | -0.63x |
|---|---|---|---|---|---|
| Enterprise Value | 679K 597K 555K 510K 957K 65.77M 974K 6.64M 2.59M 32.08M 2.55M 2.49M 111M | EV / Sales 2024 |
-0.97x | EV / Sales 2025 | 0.19x |
| Free-Float |
72.47% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.65% | ||
| 1 week | +1.99% | ||
| Current month | -20.78% | ||
| 1 month | -8.33% | ||
| 3 months | -4.94% | ||
| 6 months | -10.88% | ||
| Current year | -9.62% |
| 1 week | 7.52 |  | 7.9 |
| 1 month | 7.52 | | 14.8 |
| Current year | 3.3 | | 14.8 |
| 1 year | 3.3 | | 16.74 |
| 3 years | 3.3 | | 49.44 |
| 5 years | 3.3 | | 372 |
| 10 years | 3.3 | | 2,228.99 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/6/26 | Goodwood, Inc.
| Marche | Company | 241,570 | 7.5883% | |
| 10/23/25 | Other | Director | 0 | 0% | ||
| 10/16/25 | Other | Chief Executive Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.65% | +1.99% | -51.57% | -84.27% | 5.84M | |
| +1.07% | -3.49% | -3.25% | +12.87% | 46.35B | |
| +0.45% | +1.82% | +409.24% | +630.69% | 40.13B | |
| -0.30% | +4.70% | +10.20% | +67.33% | 36.33B | |
| +0.95% | +1.55% | +4.30% | -8.20% | 34.6B | |
| +3.14% | +1.02% | +3.72% | +34.86% | 26.77B | |
| +1.76% | -1.05% | - | - | 16.66B | |
| -0.53% | +12.66% | +32.95% | +145.33% | 16.91B | |
| +0.42% | -5.52% | +0.76% | +8.50% | 13.05B | |
| -1.11% | -0.81% | -13.53% | -30.50% | 13.05B | |
| Average | +0.52% | +0.60% | +43.65% | +86.29% | 24.38B | |
| Weighted average by Cap. | +0.75% | +0.77% | +76.06% | +137.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.59M 8.43M 7.83M 7.2M 13.51M 928M 13.75M 93.67M 36.54M 453M 35.99M 35.21M 1.57B | 7.5M 6.59M 6.13M 5.63M 10.57M 726M 10.76M 73.26M 28.57M 354M 28.15M 27.54M 1.23B |
| Net income | -15.31M -13.46M -12.51M -11.5M -21.57M -1.48B -21.96M -150M -58.34M -723M -57.47M -56.23M -2.51B | -10.36M -9.11M -8.46M -7.78M -14.6M -1B -14.86M -101M -39.47M -489M -38.89M -38.04M -1.7B |
| Net Debt | -14.08M -12.39M -11.51M -10.58M -19.85M -1.36B -20.2M -138M -53.67M -665M -52.87M -51.73M -2.31B | -5.16M -4.54M -4.21M -3.88M -7.27M -500M -7.4M -50.4M -19.66M -244M -19.36M -18.95M -845M |
Employees
28
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | $7.700 | -0.65% | 314 |
| 26-07-23 | $7.750 | +1.71% | 1,141 |
| 26-07-22 | $7.620 | -1.68% | 1,204 |
| 26-07-21 | $7.750 | +2.65% | 1,000 |
| 26-07-20 | $7.550 | -5.63% | 2,791 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CSCI Stock
Select your edition
All financial news and data tailored to specific country editions
